CONTEXT: Small for gestational age (SGA)-born children comprise a heterogeneous group in which only few genetic causes have been identified. OBJECTIVE: To determine copy number variations in 18 growth-related genes in 100 SGA children with persistent short stature. METHODS: Copy number variations in 18 growth-related genes (SHOX, GH1, GHR, IGF1, IGF1R, IGF2, IGFBP1-6, NSD1, GRB10, STAT5B, ALS, SOCS2, and SOCS3) were determined by an "in house" multiplex ligation-dependent probe amplification kit. The deletions were further characterized by single-nucleotide polymorphism array analysis. RESULTS: Two heterozygous de novo insulin-like growth factor 1 receptor (IGF1R) deletions were found: a deletion of the complete IGF1R gene (15q26.3, exons 1-21), including distally flanking sequences, and a deletion comprising exons 3-21, extending further into the telomeric region. In one case, serum IGF-I was low (-2.78 sd score), probably because of a coexisting growth hormone (GH) deficiency. Both children increased their height during GH treatment (1 mg/m(2) per day). Functional studies in skin fibroblast cultures demonstrated similar levels of IGF1R autophosphorylation and a reduced activation of protein kinase B/Akt upon a challenge with IGF-I in comparison with controls. CONCLUSIONS: IGF1R haploinsufficiency was present in 2 of 100 short SGA children. GH therapy resulted in moderate catch-up growth in our patients. A review of the literature shows that small birth size, short stature, small head size, relatively high IGF-I levels, developmental delay, and micrognathia are the main predictors for an IGF1R deletion.
CONTEXT: Small for gestational age (SGA)-born children comprise a heterogeneous group in which only few genetic causes have been identified. OBJECTIVE: To determine copy number variations in 18 growth-related genes in 100 SGA children with persistent short stature. METHODS: Copy number variations in 18 growth-related genes (SHOX, GH1, GHR, IGF1, IGF1R, IGF2, IGFBP1-6, NSD1, GRB10, STAT5B, ALS, SOCS2, and SOCS3) were determined by an "in house" multiplex ligation-dependent probe amplification kit. The deletions were further characterized by single-nucleotide polymorphism array analysis. RESULTS: Two heterozygous de novo insulin-like growth factor 1 receptor (IGF1R) deletions were found: a deletion of the complete IGF1R gene (15q26.3, exons 1-21), including distally flanking sequences, and a deletion comprising exons 3-21, extending further into the telomeric region. In one case, serum IGF-I was low (-2.78 sd score), probably because of a coexisting growth hormone (GH) deficiency. Both children increased their height during GH treatment (1 mg/m(2) per day). Functional studies in skin fibroblast cultures demonstrated similar levels of IGF1R autophosphorylation and a reduced activation of protein kinase B/Akt upon a challenge with IGF-I in comparison with controls. CONCLUSIONS:IGF1Rhaploinsufficiency was present in 2 of 100 short SGA children. GH therapy resulted in moderate catch-up growth in our patients. A review of the literature shows that small birth size, short stature, small head size, relatively high IGF-I levels, developmental delay, and micrognathia are the main predictors for an IGF1R deletion.
Authors: Hermine A van Duyvenvoorde; Julian C Lui; Sarina G Kant; Wilma Oostdijk; Antoinet C J Gijsbers; Mariëtte J V Hoffer; Marcel Karperien; Marie J E Walenkamp; Cees Noordam; Paul G Voorhoeve; Verónica Mericq; Alberto M Pereira; Hedi L Claahsen-van de Grinten; Sandy A van Gool; Martijn H Breuning; Monique Losekoot; Jeffrey Baron; Claudia A L Ruivenkamp; Jan M Wit Journal: Eur J Hum Genet Date: 2013-09-25 Impact factor: 4.246
Authors: Sophie R Wang; Heather Carmichael; Shayne F Andrew; Timothy C Miller; Jennifer E Moon; Michael A Derr; Vivian Hwa; Joel N Hirschhorn; Andrew Dauber Journal: J Clin Endocrinol Metab Date: 2013-06-14 Impact factor: 5.958
Authors: Melanie R Shapiro; Timothy P Foster; Daniel J Perry; Ron G Rosenfeld; Andrew Dauber; James A McNichols; Andrew Muir; Vivian Hwa; Todd M Brusko; Laura M Jacobsen Journal: Horm Res Paediatr Date: 2020-10-28 Impact factor: 2.852
Authors: Jan M Wit; Hermine A van Duyvenvoorde; Jan B van Klinken; Janina Caliebe; Cathy A J Bosch; Julian C Lui; Antoinet C J Gijsbers; Egbert Bakker; Martijn H Breuning; Wilma Oostdijk; Monique Losekoot; Jeffrey Baron; Gerhard Binder; Michael B Ranke; Claudia A L Ruivenkamp Journal: Horm Res Paediatr Date: 2014-10-08 Impact factor: 2.852